NKGen Biotech, Inc. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2021 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
NKGen Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2021 to 2023.
- NKGen Biotech, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$4.03M, a 17.9% increase year-over-year.
- NKGen Biotech, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$21.9M, a 2.7% increase from 2022.
- NKGen Biotech, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$22.6M, a 1380% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)